Effects of (+)catechin and (-)epicatechin on heterocyclic amines-induced oxidative DNA damage

Journal of Applied Toxicology

Volumn 31, Issue 1, 2011, Pages 53-62

  Haza, Ana Isabel ^a   Morales, Paloma ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

(+) catechin; ( ) epicatechin; Comet assay; Heterocyclic amines; Oxidative DNA damage

Indexed keywords

2 AMINO 1 METHYL 6 PHENYL IMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,4,8 TRIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; AMINE; CATECHIN; EPICATECHIN; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; PURINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMET ASSAY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; GENOTOXICITY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; IMIDAZOLES; OXIDATION-REDUCTION; QUINOXALINES;

EID: 78650450644     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1559     Document Type: Article

References (52)

1. Apostolides Z, Balentine DA, Harbowy ME, Hara Y, Weisburger JH. 1997. Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutat. Res. 389: 167-172.
2. Arts ICW, van de Putte B, Hollman PCH. 2000. Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J. Agric. Food Chem. 48: 1746-1751.
3. Arts ICW, Hollman PCH, Freskens EJM, Bueno de Mesquita HB, Kromhout D. 2001. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am. J. Clin. Nutr. 74: 227-232.
4. Burke MD, Mayer RT. 1983. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem. Biol. Interact. 45: 243-258.
5. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. 1985. Ethoxy-penthoxy and benzyloxyphexazones and homologues: a series of substrates to different induced cytochromes P450. Biochem. Pharmacol. 34: 3337-3345.
6. Cai Y, Sun M, Xing J, Luo Q, Corke H. 2006. Structure-radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci.78: 2872-2888.
7. Collins AR. 2005. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am. J. Clin. Nutr. 81: 261S-267.
8. Dashwood RH. 2002. Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models. Mutat. Res. 511: 89-112.
9. De Flora S, Ferguson LR. 2005. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591: 8-15.
10. Delgado ME, Haza AI, Arranz N, García A, Morales P. 2008. Dietary polyphenols protect against N-nitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells. Eur. J. Nutr. 47: 479-90.
11. Dolara P, Luceri C, Filippo CD, Femia AP, Giovannelli L, Caderni G, Cecchini C, Silvi S, Orpianesi C, Cresci A. 2005. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat. Res. 591: 237-246.
12. Doostdar H, Demoz A, Burke MD, Melvin WT, Grant MH. 1990. Variation in drug metabolizing enzyme activities during the growth of human HepG2 hepatoma cells. Xenobiotica 20: 435-441.
13. Felton J, Malfatti M. 2006. What do diet-induced changes in phase I and II enzymes tell us about prevention from exposure to heterocyclic amines? J. Nutr. 136: 2683S-2684.
14. Felton J, Knize M, Bennett LM, Malfatti M, Colvin M, Kulp K. 2004. Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. Toxicology 198: 135-145.
15. Halliwell B. 2002. Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic. Biol. Med. 32: 968-974.
16. Hatch FT, Lightstone FC, Colvin ME. 2000. Quantitative structure-activity relationship of flavonoids for inhibition of heterocyclic amine mutagenicity. Environ. Mol. Mutagen. 35: 279-299.
17. Hatch FT, Knize MG, Colvin ME. 2001. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency. Environ. Mol. Mutagen. 38: 268-291.
18. He Y, Friesen MD, Ruch RJ, Schut HAJ. 2000. Indole-3-carbinol as a chemopreventive agent in 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) carcinogenesis: inhibition of PhIP-DNA adduct formation, acceleration of PhIP metabolism, and induction of cytochrome P450 in female F344 rats. Food Chem. Toxicol. 38: 15-23.
19. Hodek P, Trefil P, Stiborová M. 2002. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139: 1-21.
20. Hümmerich J, Zohm C, Pfau W. 2004. Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines. Toxicology 199: 231-240.
21. IARC. 1993. Some Natural Occurring Substances: Food Items and Constituents, Heterocyclic Amines and Mycotoxins. Monographs on the Evaluation of Carcinogenic Risks to Humans, 56. International Agency for Research on Cancer: Lyon; 165-231.
22. Kampa M, Nifli A, Notas G, Castanas E. 2007. Polyphenols and cancer cell growth. Rev. Physiol. Biochem. Pharmacol. 159: 79-113.
23. Knasmuller S, Schwab CE, Land SJ, Wang CY, Sanyal R, Kundi M, Parzefall W, Darroudi F. 1999. Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. Mutagenesis 14: 533-540.
24. Lambert JD, Hong J, Yang G, Liao J, Yang CS. 2005. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations, Am. J. Clin. Nutr. 81: 284-291.
25. Lilienblum W, Walli AK, Bock KW. 1982. Differential induction of rat liver microsomal UDP-glucuronosyltransferase activites by various inducing agents. Biochem. Pharmacol. 31: 907-913.
26. Lotito SB, Frei B. 2004. Relevance of apple polyphenols as antioxidants in human plasma: Contrasting in vivo and in vitro effects. Free Rad. Biol. Med. 36: 201-211.
27. Maggiolini M, Recchia AG, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Ando S. 2005. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor {alpha} in human breast cancer cells. J. Mol. Endocrinol. 35: 269-281.
28. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. 2005. Bioavailability and bioefficiency of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81: 230S-242S.
29. Mendoza-Wilson AM, Glossman-Mitnik D. 2006. Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (-)-epicatechin related to their antioxidant ability. J. Mol. Struct. Theochem. 761: 97-106.
30. Mersch-Sundermann V, Knasmuller S, Wu X, Darroudi F, Kassie F. 2004. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 198: 329-340.
31. Moon YJ, Wang X, Morris ME. 2006. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol. in Vitro 20: 187-210.
32. Murata M, Kobayashi M, Kawanishi S. 1999. Mechanism of oxidative DNA damage induced by a heterocyclic amine, 2-amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline. Cancer Sci. 90: 268-275.
33. Neuhouser ML. 2004. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr. Cancer 50: 1-7.
34. Nowell SA, Massengill JS, Williams S, Radominska-Pandya A, Tephly TR, Cheng Z, Strassburg CP, Tukey RH, MacLeod SL, Lang NP, Kadlubar FF. 1999. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 20: 1107-1114.
35. Olive PL, Wlodek D, Durand RE, Banáth JP. 1992. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp. Cell Res. 198: 259-267.
36. Pfau W, Martin FL, Cole KJ, Venitt S, Phillips DH, Grover PL, Marquardt H. 1999. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. Carcinogenesis 20: 545-551.
37. Plazar J, Žegura B, Lah TT, Filipić M. 2007. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutat. Res. 632: 1-8.
38. Ricardo da Silva JM, Rigaud J, Cheynier V, Cheminat A, Moutounet M. 1991. Procyanidin dimers and trimers from grape seeds. Phytochemistry 30: 1259-1264.
39. Ristic A, Cichna, M, Sontag G. 2004. Determination of less polar heterocyclic aromatic amines in standardized beef extracts and cooked meat consumed in Austria by liquid chromatography and fluorescence detection. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 802: 87-94.
40. Sánchez Moreno C, Larrauri JA, Saura Calixto F. 1998. A procedure to measure the antiradical efficiency of polyphenols. J. Sci. Food Agric. 76: 270-276.
41. Sinha R. 2002. An epidemiologic approach to studying heterocyclic amines. Mutat. Res. 506-507: 197-204.
42. Skog KI, Johansson MAE, Jägerstad MI. 1998. Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. Food Chem. Toxicol. 36: 879-896.
43. Sugimura T. 1997. Overview of carcinogenic heterocyclic amines. Mutat. Res. 376: 211-219.
44. Sugimura T. 2002. Food and cancer. Toxicology 181-182: 17-21.
45. Thompson LH, Wu RW, Felton JS. 1995. Genetically modified Chinese hamster ovary (CHO) cells for studying the genotoxicity of heterocyclic amines from cooked foods. Toxicol. Lett. 82-83: 883-889.
46. Toribio F, Busquets R, Puignou L, Galceran MT. 2007. Heterocyclic amines in griddled beef steak analysed using a single extract clean-up procedure. Food Chem. Toxicol. 45: 667-675.
47. Turesky RJ. 2002. Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab. Rev. 34: 625-650.
48. Uhl M, Helma C, Knasmueller S. 2000. Evaluation of the single cell gel electrophoresis assay with human hepatoma (HepG2) cells. Mutat. Res. 468: 213-225.
49. Weisburger JH. 2002. Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutat. Res. 506-507: 9-20.
50. Weisburger JH, Chung F. 2002. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol. 40: 1145-1154.
51. Westerink MA, Schoonen GEJ. 2007. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. in Vitro 21: 1581-1591.
52. Yao LH, Jiang YM, Shi J, Tomas-Barberan FA, Datta N, Singanusong R, Chen SS. 2004. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 59: 113-122.